10
Participants
Start Date
April 13, 2023
Primary Completion Date
June 1, 2023
Study Completion Date
June 1, 2023
SLN mapping using technetium-99m +/- isosulfan blue dye
The isosulfan blue dye injection will be performed by the participating surgeon in the operating room; as per standard of care, injection will be subareolar. Incisions will be planned based on the technetium-99m activity or at the lateral aspect of the pectoralis muscle, per usual care.
SLN mapping with ICG fluorescence using the Asimov Platform
2 ml (5 mg) of ICG solution will be injected intradermally in 1-4 injection sites in the lateral areolar region. After injection, gentle manual massage will be performed for 5 minutes. ICG imaging will be obtained prior to incision. After incision is made (following standard of care procedures), the axilla will be visualized using the Asimov Platform to assess for ICG-fluorescence in sentinel lymph nodes.
University of Wisconsin, Madison
Collaborators (1)
OnLume Inc.
INDUSTRY
National Cancer Institute (NCI)
NIH
University of Wisconsin, Madison
OTHER